MACKENZIE LAWSON: Open Payments
NPI 1568050177 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 106 payments from 28 companies in 2025. Trend: 2023 $2,702 · 2024 $4,277 · 2025 $2,156
Food & beverage: $2,156
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $384 |
| UCB, Inc. | 8 | $178 |
| Amneal Pharmaceuticals LLC | 11 | $177 |
| MDD US Operations, LLC | 10 | $154 |
| HARMONY BIOSCIENCES LLC | 3 | $123 |
| Vanda Pharmaceuticals Inc. | 4 | $107 |
| PFIZER INC. | 5 | $93 |
| Lundbeck LLC | 3 | $89 |
| Neurocrine BioSciences, Inc. | 3 | $79 |
| Lilly USA, LLC | 4 | $74 |
Products named: QULIPTA, CREXONT, Apokyn, WAKIX, PONVORY, Briviact, NURTEC ODT, VYEPTI.
Industry payments across IN — which companies pay providers there.
